Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...
MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
In 2023, the Home Office – Britain's interior ministry - identified around 17,000 people as potential victims of modern ...
The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback